Loading...
XHKG8037
Market cap60mUSD
Dec 23, Last price  
0.48HKD
1D
-2.04%
1Q
84.62%
Jan 2017
33.33%
Name

China Biotech Services Holdings Ltd

Chart & Performance

D1W1MN
XHKG:8037 chart
P/E
—
P/S
2.21
EPS
—
Div Yield, %
2.06%
Shrs. gr., 5y
1.78%
Rev. gr., 5y
24.70%
Revenues
212m
-88.55%
197,457,000243,386,000270,753,000272,277,000160,522,00084,184,00045,017,000101,354,00085,300,000140,385,00034,127,00086,565,000105,135,00070,304,00059,214,000655,792,000623,761,0001,851,532,000211,985,000
Net income
-95m
L
25,165,000528,000-38,333,000-37,425,000-83,561,000-16,465,000-43,555,000-20,698,000-60,231,200-82,929,000-62,269,000-50,151,000-63,022,000-64,250,000-107,483,000167,623,000132,572,000705,568,000-95,447,000
CFO
195m
-59.57%
18,596,00022,720,000-18,547,000-20,636,0008,362,000-1,508,000-27,020,000-1,574,000-41,720,000-40,011,000-85,123,000-25,392,000-56,951,000-14,759,000-30,306,000421,999,00040,505,000482,748,000195,193,000
Dividend
May 19, 20230.01 HKD/sh
Earnings
Jun 05, 2025

Profile

China Biotech Services Holdings Limited, an investment holding company, provides medical laboratory testing and health check services in the People's Republic of China and Hong Kong. The company operates through five segments: Immunotherapy, Pharmaceutical Products, Medical and Health Related Services, Securities, Insurance brokerage, and Others segments. It also engages in the research, development, manufacture, sale, and distribution of health related and pharmaceutical products; trading of securities; money lending business; provision of tumor immune cell therapy, immune cell storage, and health management services; and provision of coordination of healthcare providers services. In addition, the company markets and sells health supplements, slimming pills, Chinese medicines, and beauty products; trades in pharmaceutical intermediates; and offers insurance brokerage services. Further, it provides property investment and logistic services. The company was formerly known as Rui Kang Pharmaceutical Group Investments Limited and changed its name to China Biotech Services Holdings Limited in November 2017. China Biotech Services Holdings Limited was founded in 1996 and is headquartered in Causeway Bay, Hong Kong.
URL
http://www.cbshhk.com/
IPO date
Jun 17, 2004
Employees
187
Domiciled in
HK
Incorporated in
BM

Valuation

Title
HKD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
211,985
-88.55%
1,851,532
196.83%
623,761
-4.88%
Cost of revenue
359,655
1,033,217
463,223
Unusual Expense (Income)
NOPBT
(147,670)
818,315
160,538
NOPBT Margin
44.20%
25.74%
Operating Taxes
(1,319)
157,258
48,096
Tax Rate
19.22%
29.96%
NOPAT
(146,351)
661,057
112,442
Net income
(95,447)
-113.53%
705,568
432.21%
132,572
-20.91%
Dividends
(9,632)
Dividend yield
1.30%
Proceeds from repurchase of equity
(3,637)
(2,985)
(4,310)
BB yield
0.49%
0.27%
0.32%
Debt
Debt current
94,669
16,621
63,614
Long-term debt
21,283
85,510
14,688
Deferred revenue
(9,936)
Other long-term liabilities
22,252
9,936
Net debt
(13,055)
(218,357)
(194,273)
Cash flow
Cash from operating activities
195,193
482,748
40,505
CAPEX
(62,884)
(69,750)
(12,216)
Cash from investing activities
(67,531)
(256,311)
(8,124)
Cash from financing activities
(149,412)
(281,959)
(266,611)
FCF
(9,778)
377,752
154,607
Balance
Cash
72,087
92,770
152,313
Long term investments
56,920
227,718
120,262
Excess cash
118,408
227,911
241,387
Stockholders' equity
34
335,828
(24,797)
Invested Capital
591,088
460,647
472,666
ROIC
141.66%
21.12%
ROCE
117.50%
35.07%
EV
Common stock shares outstanding
963,231
963,231
964,714
Price
0.77
-33.04%
1.15
-16.67%
1.38
6.15%
Market cap
741,688
-33.04%
1,107,716
-16.79%
1,331,305
5.74%
EV
756,605
1,113,204
1,207,529
EBITDA
(92,090)
884,716
228,650
EV/EBITDA
1.26
5.28
Interest
5,311
3,495
6,543
Interest/NOPBT
0.43%
4.08%